Now that the auction date is set for Affymax physical asset sale....
and the wind-down of operations has occured, thus operating expenses have been cut, the only thing left to due is sell the intellectual property/potential milestone and royalty rights. Takeda should just make a tender offer before someone swoops in, makes an offer for the rights, and drives the price up a bit and drags this out.
Rest assured, although nothing tangible remains at Laffy HQ, both Takeda and the LAFFY BOD will make absolutely certain that LaffyStock common shareholders are properly taken of. They will never forget that the common shareholders must get their just due. Otherwise, it just would not be right and it would not be fair. They would never let something like that happen. You can be sure that your interests will be looked after. Do not be at all concerned. Thank you.
How could you forget AFFY resolving all of the litigation against it? Oh. That's right. Takeda will hold AFFY and its shareholders harmless from any litigation expense, and also insurance will be more than adequate despite AFFY's disclosures that it might not be.
The fact that potential hyper-sensitive reactions could occur by using Omontys, which was known in the trials 1 thru 3, and was warned about on the label of the drug, should be enough to win the suits. In addition, the dialysis centers should have done tests on patients to recognize potential allergic reactions, which would occur with-in 30 minutes after the #$%$ test, hince they would be held liable.